|Articles|October 4, 2021
BioAgilytix Announces New Partnership With CTI
Advertisement
BioAgilytix Labs, LLC, a global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announced that it signed a formal, worldwide partnership agreement with global contract research organization Clinical Trial and Consulting Services (CTI). The partnership enables both BioAgilytix and CTI to provide their customers with mutually complementary services.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5